167 related articles for article (PubMed ID: 21642011)
1. Structure-activity relationship of ibogaine analogs interacting with nicotinic acetylcholine receptors in different conformational states.
Arias HR; Feuerbach D; Targowska-Duda KM; Jozwiak K
Int J Biochem Cell Biol; 2011 Sep; 43(9):1330-9. PubMed ID: 21642011
[TBL] [Abstract][Full Text] [Related]
2. Interaction of 18-methoxycoronaridine with nicotinic acetylcholine receptors in different conformational states.
Arias HR; Rosenberg A; Feuerbach D; Targowska-Duda KM; Maciejewski R; Jozwiak K; Moaddel R; Glick SD; Wainer IW
Biochim Biophys Acta; 2010 Jun; 1798(6):1153-63. PubMed ID: 20303928
[TBL] [Abstract][Full Text] [Related]
3. Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptors.
Arias HR; Feuerbach D; Targowska-Duda KM; Jozwiak K
Neurochem Int; 2010 Sep; 57(2):153-61. PubMed ID: 20493225
[TBL] [Abstract][Full Text] [Related]
4. (-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
Arias HR; Ortells MO; Feuerbach D
Neurochem Int; 2013 Nov; 63(5):423-31. PubMed ID: 23917086
[TBL] [Abstract][Full Text] [Related]
5. Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
Arias HR; Targowska-Duda KM; Feuerbach D; Jozwiak K
Int J Biochem Cell Biol; 2015 Aug; 65():81-90. PubMed ID: 26022277
[TBL] [Abstract][Full Text] [Related]
6. Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula.
Arias HR; Jin X; Feuerbach D; Drenan RM
Int J Biochem Cell Biol; 2017 Nov; 92():202-209. PubMed ID: 29042244
[TBL] [Abstract][Full Text] [Related]
7. Interaction of bupropion with muscle-type nicotinic acetylcholine receptors in different conformational states.
Arias HR; Gumilar F; Rosenberg A; Targowska-Duda KM; Feuerbach D; Jozwiak K; Moaddel R; Wainer IW; Bouzat C
Biochemistry; 2009 Jun; 48(21):4506-18. PubMed ID: 19334677
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory mechanisms and binding site location for serotonin selective reuptake inhibitors on nicotinic acetylcholine receptors.
Arias HR; Feuerbach D; Bhumireddy P; Ortells MO
Int J Biochem Cell Biol; 2010 May; 42(5):712-24. PubMed ID: 20079457
[TBL] [Abstract][Full Text] [Related]
9. Interaction of ibogaine with human alpha3beta4-nicotinic acetylcholine receptors in different conformational states.
Arias HR; Rosenberg A; Targowska-Duda KM; Feuerbach D; Yuan XJ; Jozwiak K; Moaddel R; Wainer IW
Int J Biochem Cell Biol; 2010 Sep; 42(9):1525-35. PubMed ID: 20684041
[TBL] [Abstract][Full Text] [Related]
10. Different interaction between tricyclic antidepressants and mecamylamine with the human alpha3beta4 nicotinic acetylcholine receptor ion channel.
Arias HR; Targowska-Duda KM; Feuerbach D; Sullivan CJ; Maciejewski R; Jozwiak K
Neurochem Int; 2010 Mar; 56(4):642-9. PubMed ID: 20117161
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional interaction of (±)-2-(N-tert-butylamino)-3'-iodo-4'-azidopropiophenone, a photoreactive bupropion derivative, with nicotinic acetylcholine receptors.
Arias HR; Feuerbach D; Targowska-Duda KM; Aggarwal S; Lapinsky DJ; Jozwiak K
Neurochem Int; 2012 Dec; 61(8):1433-41. PubMed ID: 23103524
[TBL] [Abstract][Full Text] [Related]
12. Functional and structural interaction of (-)-reboxetine with the human α4β2 nicotinic acetylcholine receptor.
Arias HR; Fedorov NB; Benson LC; Lippiello PM; Gatto GJ; Feuerbach D; Ortells MO
J Pharmacol Exp Ther; 2013 Jan; 344(1):113-23. PubMed ID: 23010362
[TBL] [Abstract][Full Text] [Related]
13. Differential pharmacological activity of JN403 between α7 and muscle nicotinic acetylcholine receptors.
Arias HR; De Rosa MJ; Bergé I; Feuerbach D; Bouzat C
Biochemistry; 2013 Nov; 52(47):8480-8. PubMed ID: 24164482
[TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.
Gerzanich V; Peng X; Wang F; Wells G; Anand R; Fletcher S; Lindstrom J
Mol Pharmacol; 1995 Oct; 48(4):774-82. PubMed ID: 7476906
[TBL] [Abstract][Full Text] [Related]
15. Tricyclic antidepressants and mecamylamine bind to different sites in the human alpha4beta2 nicotinic receptor ion channel.
Arias HR; Rosenberg A; Targowska-Duda KM; Feuerbach D; Jozwiak K; Moaddel R; Wainer IW
Int J Biochem Cell Biol; 2010 Jun; 42(6):1007-18. PubMed ID: 20223294
[TBL] [Abstract][Full Text] [Related]
16. Noncompetitive antagonist binding sites in the torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives.
Arias HR; Trudell JR; Bayer EZ; Hester B; McCardy EA; Blanton MP
Biochemistry; 2003 Jun; 42(24):7358-70. PubMed ID: 12809491
[TBL] [Abstract][Full Text] [Related]
17. Conformational mobility of immobilized alpha3beta2, alpha3beta4, alpha4beta2, and alpha4beta4 nicotinic acetylcholine receptors.
Moaddel R; Jozwiak K; Whittington K; Wainer IW
Anal Chem; 2005 Feb; 77(3):895-901. PubMed ID: 15679359
[TBL] [Abstract][Full Text] [Related]
18. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.
Parker MJ; Beck A; Luetje CW
Mol Pharmacol; 1998 Dec; 54(6):1132-9. PubMed ID: 9855644
[TBL] [Abstract][Full Text] [Related]
19. Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes.
Carbonnelle E; Sparatore F; Canu-Boido C; Salvagno C; Baldani-Guerra B; Terstappen G; Zwart R; Vijverberg H; Clementi F; Gotti C
Eur J Pharmacol; 2003 Jun; 471(2):85-96. PubMed ID: 12818695
[TBL] [Abstract][Full Text] [Related]
20. Interaction of d-tubocurarine analogs with the mouse nicotinic acetylcholine receptor. Ligand orientation at the binding site.
Papineni RV; Pedersen SE
J Biol Chem; 1997 Oct; 272(40):24891-8. PubMed ID: 9312090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
